Quick Answer
Renalytix plc reported Diluted EPS of $0.31 per share (loss) for fiscal year 2024.
Renalytix plc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.31 | +43.6% |
| 2023 | -$0.55 | +17.9% |
| 2022 | -$0.67 | -36.7% |
| 2021 | -$0.49 | -188.2% |
| 2020 | -$0.17 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$0.04 | +63.6% | +50.0% |
| March 31, 2024 | -$0.08 | +42.9% | +11.1% |
| December 31, 2023 | -$0.09 | +35.7% | +18.2% |
| September 30, 2023 | -$0.11 | +31.2% | +21.4% |
| March 31, 2023 | -$0.14 | — | +0.0% |
| December 31, 2022 | -$0.14 | — | +12.5% |
| September 30, 2022 | -$0.16 | — | — |
- Renalytix plc showed an increase of +43.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, Renalytix plc’s diluted eps has declined by 82.4% (from $0.17 per share (loss) to $0.31 per share (loss)).
- The most recent figure is from Renalytix plc’s fiscal year 2024 report (Form 10-K), filed with the SEC on September 30, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: